RWEality
RWEality is a French consulting firm founded in 2023 that provides Real-World Evidence strategy, HEOR modeling, market access, and organizational impact assessments to pharmaceutical, biotechnology, medical device, government, and payer clients navigating the French HTA system.
- Company typePrivate
- Founded2023
- HeadquartersParis, France
- Headcount1–10
- GTM typeB2B
- OfferingServices
What RWEality does
RWEality is a Paris- and Bondoufle-based research and consulting firm founded in 2023 that specializes in Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) for the French healthcare market. The firm was co-founded by health economist Sandrine Bourguignon and biotech executive Jean-François Boyer, and operates as a SAS (Société par Actions Simplifiées) with €10,000 of share capital. Services are organized around three pillars — Strategy, Insights, and Operations — and cover RWE strategy development, HEOR modeling, market-access and pricing strategy, organizational and budget impact modeling (including the proprietary OBIM methodology), patient-pathway analysis, primary data generation (with partners Horiana and SKEZI), scientific communication, and training. Customers include pharmaceutical and biotechnology companies, medical-device manufacturers, French government and regional health agencies, patient associations, and health insurers; the firm's project portfolio is anchored in navigating French HTA processes (HAS, CEESP, CNEDIMTS, Article 51).
Revenue is generated exclusively through customized professional-service fees on a project basis, with no packaged products or standard pricing tiers publicly disclosed. The GTM motion is sales-led and direct: the firm markets through LinkedIn, YouTube webinars, and active speaker participation at ISPOR, ACIP, and SNITEM events, and delivers engagements through its in-house expert consultants rather than through intermediaries. The firm maintains a strategic partnership with Enosium Life Science (visible in co-branded logo/marketing), holds the registered RWEality trademark under Sandrine Bourguignon, and has developed a peer-reviewed publication track across journals such as Journal of Medical Economics, Therapie, and Value in Health. The operating model is bottlenecked by a small bench (approximately 10 team members including apprentices and interns), making senior-consultant utilization and repeat pharma/biotech engagement the primary scaling constraints.
RWEality firmographics
Firmographics- Name
- RWEality
- Legal name
- RWEality
- Website
- https://rweality.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- RWEality is a French consulting firm founded in 2023 that provides Real-World Evidence strategy, HEOR modeling, market access, and organizational impact assessments to pharmaceutical, biotechnology, medical device, government, and payer clients navigating the French HTA system.
- Ownership category
- akta.pro rank
RWEality industry classification
Industry- Product category
- Healthcare Economics Consulting
- NAICS
- Management Consulting Services (54161), Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Engineering, Accounting, Research, Management (8700), Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
- akta.pro primary industry
- Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK)
- akta.pro secondary industries
- Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN), Real-World Evidence (RWE) & HEOR for Development (HLAIALAI), Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)
Keywords
Where RWEality is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
RWEality business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Healthcare Consulting Services: RWEality provides specialized consulting services including RWE strategy development, health economics and outcomes research (HEOR), market access and pricing strategy, organizational impact assessments, and economic modeling. Revenue is generated through professional service fees for studies, assessments, and strategic consulting engagements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Consulting services with customized pricing based on project scope |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
RWEality product offering
Product offeringCore offering
RWEality is a research and consulting firm that evaluates public policies, healthcare technologies, and clinical practices for pharmaceutical, biotechnology, medical device, and institutional clients. The firm specializes in Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR), delivering economic modeling, market access and pricing strategy, organizational and budget impact assessments (OBIM), patient pathway analysis, data generation planning, and scientific communication support. Services are delivered by expert consultants and structured around four pillars: Strategy, Insights, Data Generation, and Communication.
Product overview
RWEality is a healthcare consulting firm offering end-to-end services organized around three pillars: Strategy, Insights, and Operations. The company provides RWE Strategy services (including RWE plan, investment, gap analysis, and market access), Insight services (HEOR modeling, organizational and budget impact assessment), Data Generation Plan services (data collection, management, statistical analysis, secondary data sources), and Communication services. Their core offerings are consulting and advisory services rather than a software product platform. They work with pharmaceutical, biotech, medical device companies, and healthcare institutions to demonstrate the value of healthcare technologies through robust methodologies, data analysis, and strategic market access support.
Differentiator
Problem solved
Functional benefit
Products and services
- RWE Strategy Services
- Insight Services (HEOR)
- Data Generation Plan
- Communication Services
- Organizational and Budget Impact Model (OBIM)
- Local Market Access Services
- Value Communication & Training
Quantifiable outcome
- Multiple peer-reviewed publications in health economics journals including Journal of Medical Economics, Journal of Liver Transplantation, Therapie, ESC Heart Fail, and Value in Health
- +1 more outcomes
Companies that use RWEality
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
RWEality technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
RWEality partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Enosium Life SciencecoreStrategic partnership for life sciences consulting and research collaboration in the healthcare sector.
- HorianacoreData generation partner for collection, data management, and statistical analysis services. Collaboration specifically mentioned in data generation services section.
- SKEZIcoreData generation partner for data collection and statistical analysis. Collaboration mentioned for data generation services including PRO data and digital health solutions.
- Perrine BocquinminorWebsite designer and developer providing web development services for the company website.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
RWEality competitors and assessment
Company assessmentDirect peers
- Charles River Associates (CRA): Global consulting firm with a Life Sciences practice providing HEOR, pricing, market access, and value strategy services. Competes for pharma/biotech HEOR and pricing engagements with similar deep economic expertise.
- Putnam Associates: Strategy consulting firm focused on biopharmaceutical market access, pricing, and HEOR. Competes with RWEality on pharma/biotech pricing strategy and value demonstration engagements.
- Alira Health: Global healthcare and life sciences consulting firm offering RWE, HEOR, market access, and patient-centric services. RWEality's Analyst José Fernandes Soares previously worked at Alira Health, and the firms compete for similar pharma/biotech/medical device RWE/HEOR engagements.
- Evidera (PPD / Thermo Fisher): Major global RWE/HEOR consulting firm within PPD/Thermo Fisher Scientific, offering health economics, market access, and real-world evidence services to pharma and biotech. Competes with RWEality on large enterprise RWE and HEOR engagements.
- Enosium Life Science: European life sciences consulting firm with RWE, HEOR, and market access practices. RWEality has a Core strategic partnership with Enosium, and the firms operate in adjacent/similar European healthcare consulting niches.
Broad incumbents
- ICON plc: Global CRO with significant HEOR, RWE, and market access consulting capabilities post-PRA Health Sciences acquisition. Competes with RWEality on large pharma RWE and value demonstration engagements.
- IQVIA: Global life sciences and healthcare data giant with extensive HEOR, RWE, and market access consulting practices. Several RWEality team alumni (Nathalie Grémaud, Enguérand Dautel) previously worked at IQVIA, and IQVIA serves as both a competitor and a source of trained talent.
- Cencora (formerly AmerisourceBergen) Consulting Services: Large pharmaceutical distribution and consulting services provider with market access and HEOR capabilities serving pharma manufacturers. Competes in the broader market access and value demonstration space.
Regional players
- Stratégique Santé: French public affairs and health economics consulting firm where RWEality's Public Health Director Nathalie Grémaud previously worked. Directly competes for French healthcare market access and policy engagements.
- Niveco: French health economics and market access consulting boutique serving pharma and medical device clients with HEOR, pricing, and reimbursement services. Closest French boutique peer competing for the same client base.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
RWEality social profiles
Digital presenceRWEality financial estimates
Financial estimateRevenue estimate
Valuation estimate
RWEality leadership team
Management profileNumber of profiles
Profiles10 records
RWEality funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RWEality M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RWEality
What does RWEality do?
RWEality is a research and consulting firm that evaluates public policies, healthcare technologies, and clinical practices for pharmaceutical, biotechnology, medical device, and institutional clients. The firm specializes in Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR), delivering economic modeling, market access and pricing strategy, organizational and budget impact assessments (OBIM), patient pathway analysis, data generation planning, and scientific communication support. Services are delivered by expert consultants and structured around four pillars: Strategy, Insights, Data Generation, and Communication.
Is RWEality a public or private company?
RWEality is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was RWEality founded?
RWEality was founded in 2023. It employs 1 to 10 people.
Where is RWEality based?
RWEality is headquartered in Paris, France, in the Europe region.
How does RWEality make money?
One revenue line is on record: healthcare Consulting Services.
Who are RWEality's main competitors?
Direct peers on record are Charles River Associates (CRA), Putnam Associates, Alira Health, Evidera (PPD / Thermo Fisher) and Enosium Life Science. Broad incumbents are ICON plc, IQVIA and Cencora (formerly AmerisourceBergen) Consulting Services. Regional players are Stratégique Santé and Niveco.
Does RWEality have an API?
No public API is recorded for RWEality.
What industry is RWEality in?
RWEality's product category is Healthcare Economics Consulting. Its primary akta.pro industry code is HLAGAAAK, Real-World Evidence (RWE), HEOR & Epidemiology CROs, with a secondary code of BPAHALAN, Healthcare Outcomes & Real-World Evidence (RWE) Analytics. Its NAICS code is 54161 and its SIC code is 8700.